Evaluation of antihyperglycemic and hypolipidemic activity of ethanolic extract of Clerodendrum infortunatum Linn. in experimental animals

Yasmeen A. Maniyar, C. R. Roopa, C. H. Janaki Devi


Background: Diabetes mellitus (DM) is the most common non-communicable disease of the modern world. The study of plants having antihyperglycemic and hypolipidemic activities may give a new approach in the treatment of DM. The study was intended to evaluate the antihyperglycemic and hypolipidemic activity of ethanolic extract of Clerodendrum infortunatum Linn. (EECL) in alloxan-induced diabetic albino rats.

Methods: Diabetes was induced in albino rats by administration of alloxan monohydrate (160 mg/kg, intraperitoneal). Rats were divided into six groups of six animals each. First group served as non-diabetic control, second group as diabetic control, third group as standard and was treated with 0.1 mg/kg/day of glibenclamide. Group 4, 5, and 6 received 200 and 400 mg/kg body weight of EECL. Blood samples were analyzed for blood glucose on day 1, 3, 7, 14, 21, and 28 and lipid profile on day 28.

Results: The EECL showed a significant reduction (p<0.001) in blood glucose level and serum lipid profile levels with 400 mg/kg body weight in alloxan induced diabetic rats as compared with control.

Conclusion: It is concluded that EECL is effective in controlling blood glucose levels and in improving lipid profile in diabetic rats.


Ethanolic extract, Hypoglycemia, Hypolipidemia, Clerodendrum infortunatum Linn

Full Text:



Kasper DL, Braunwald E, Faucis AS, Hauser SL, Longo DL, Jamson JL, et al., editors. Harrison’s Principles of Internal Medicine. 17th Edition. Vol. 2. New York: McGraw Hill; 2008: 2275.

Available at Accessed 15 January 2015.

Yadav JP, Sushila S, Kalia AN, Dangi AS. Hypoglycemic and hypolipidemic activity of ethanolic extract of Salvadora oleoides in normal and alloxan induced diabetic rats. Indian J Pharmacol. 2008; 40 (1): 23-7.

Malloy MJ, Kane JP. Agents used in dyslipidemia. In: Katzung BG, editor. Basic and Clinical Pharmacology. 12th Edition. New Delhi: Tata McGraw Hill; 2012: 619-33.

Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Bruton LL, editor. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 12th Edition. New York: McGraw Hill; 2011: 877-908.

Libby P. The pathogenesis, prevention, treatment of atherosclerosis. In: Lango DL, Fauci AS, Kasper DL, editors. Harrison’s Principle of Internal Medicine. 18th Edition. New York: McGraw Hill; 2012: 1983-92.

Bhattacharjee D, Das A, Das SK, Chakraborthy GS. Clerodendrum infortunatum Linn: a review. Adv Pharm Health Care Res. 2011;1(3):82-5.

Das S, Haldar PK, Pramanik G, Suresh RB. Evaluation of anti-inflammatory activity of Clerodendron infortunatum Linn. extract in rats. Glob J Pharm. 2010;4(1):48-50.

Baid SS. Evaluation of antihyperglycemic and hypolipidemic activities of Clerodendrumn infortunatum Linn. leaf extracts. Asian J Complement Altern Med. 2013;1(1):1-8.

Das S, Haldar PK, Pramanik G, Suresh RB. Anticonvulsant activity of methanolic extract of Clerodendron infortunatum Linn. in Swiss albino mice. Thai J Pharm Sci. 2010;34:129-33.

Girish G, Das K, Bhosle V, Einstein JW, Mathai KB. Evaluation of anticonvulsant activity of ethanolic leaves extract of Desmodium triflorum in mice. Rev Bras Farmacogn Braz J Pharmacogn. 2012;22(3):649-56.

Maniyar Y, Bhixavathimath P. Antihyperglycemic and hypoglycemic activities of aqueous extract of Carica papaya Linn. Leaves in alloxan-induced diabetic rats. J Ayurveda Integr Med. 2012;3(2):70-4.

Demacker PN, Hessels M, Toenhake-Dijkstra H, Baadenhuijsen H. Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio. Clin Chem. 1997;43(4):663-8.

McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983;29(3):538-42.

Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537-46.

Marshall A, Gingerich RL, Wright PH. Hepatic effect of sulfonylureas. Metabolism. 1970;19(12):1046-52.

Widén E. Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus? Scand J Clin Lab Invest. 1993;53(4):395-403.